10-Q: HeartCore Enterprises Reports Q2 2026 Results, Net Loss Widens

HeartCore Enterprises, Inc. reported a net loss of $2.04 million for the second quarter of 2026, a significant increase from the prior year's net income, driven by rising costs and the impact of discontinued operations.

Summary

• HeartCore Enterprises, Inc. reported a net loss of $2,039,519 for the three months ended June 30, 2026, compared to a net income of $1,061,506 for the same period in 2025.
• Revenues increased by 71.6% to $321,428 for the three months ended June 30, 2026, driven by software development services, but offset by a decrease in Go IPO consulting services.
• Cost of revenues increased by 86.3% to $391,643 for the three months ended June 30, 2026, leading to a gross loss of $70,215.
• The company reported a net loss from continuing operations of $1,550,289 for the three months ended June 30, 2026.
• Cash and cash equivalents decreased to $587,074 as of June 30, 2026, from $1,904,826 as of December 31, 2025.
• The company completed the sale of its 51% interest in Sigmaways and its subsidiaries on June 22, 2026, and is expected to complete the sale of its 51% interest in HeartCore Luvina on or before August 14, 2026.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as negative due to significant net losses, increased cost of revenues, and a substantial decrease in cash and cash equivalents, despite revenue growth in software development services.

Positives

• Revenues increased by 71.6% to $321,428 for the three months ended June 30, 2026, primarily due to increased customer orders for software development services from HeartCore Luvina.
• Gross profit from software development services increased due to cost control policies and enhanced efficiency.
• The company regained compliance with the Nasdaq Minimum Bid Price Requirement as of April 20, 2026.

Negatives

• The company reported a net loss of $2,039,519 for the three months ended June 30, 2026, a significant increase from the prior year's net income.
• Cost of revenues increased by 86.3% for the three months ended June 30, 2026, outpacing revenue growth and resulting in a larger gross loss.
• Gross loss increased by 205.7% to $70,215 for the three months ended June 30, 2026.
• Net loss from continuing operations was $1,550,289 for the three months ended June 30, 2026.
• Cash and cash equivalents significantly decreased from $1,904,826 at the end of 2025 to $587,074 at the end of Q2 2026.
• The company has an accumulated deficit of $17,650,321 as of June 30, 2026.
• The sale of Sigmaways and its subsidiaries resulted in a loss on sale of discontinued operations of $423,496 for the six months ended June 30, 2026.

Risks

• Following the sale of Sigmaways, revenue is now more concentrated among a smaller group of customers, increasing volatility and unpredictability of financial performance.
• Deterioration in the financial condition of key customers or general macroeconomic weakness could increase credit risk and lead to delays or defaults in accounts receivable payments.
• The earn-out consideration from the Sigmaways sale is contingent on future performance, and there is no assurance it will be realized.
• The company's ability to continue as a going concern is subject to doubt due to net losses and negative cash flows from operations, with plans to raise additional funding potentially constrained by market conditions and share price.

Future Outlook

The company's ability to continue as a going concern is subject to doubt due to ongoing net losses and negative cash flows from continuing operations. Management plans to explore strategic alternatives for raising additional funding through equity financing, debt arrangements, and operational restructuring. However, additional funding may not be available on favorable terms or at all, and could dilute current shareholders.

Management Comments

• The company incurred net loss from continuing operations of $1.6 million and $3.3 million for the three and six months ended June 30, 2026, respectively, and net cash flows used in operating activities of continuing operations of $2.5 million for the six months ended June 30, 2026, primarily due to the macroeconomic downturn environment.
• Management cannot conclude as of the date of this report that its plans are probable of being successfully implemented.
• There can be no assurance that the Company will be able to obtain sufficient additional liquidity when needed or under acceptable terms, if at all.

Industry Context

StockSavvy.ai notes that HeartCore Enterprises is navigating a challenging market, evidenced by the strategic divestitures of its software business units (HeartCore Japan and Sigmaways). The company is focusing on its Go IPO consulting services, a niche that requires significant client support and can be sensitive to market conditions and IPO timelines. The increased losses and reduced cash position highlight the capital-intensive nature of supporting clients through the IPO process and the ongoing need for funding.

Comparison to Industry Standards

• The company's revenue growth in software development services, particularly from its Vietnamese subsidiary HeartCore Luvina, aligns with the trend of companies leveraging offshore development for cost-effectiveness and scalability.
• However, the significant increase in cost of revenues and gross loss in the Go IPO consulting segment suggests potential pricing pressures or higher-than-expected operational costs compared to industry benchmarks for similar advisory services.
• The company's focus on Go IPO consulting services places it in a specialized segment of the financial advisory market. Benchmarking against broader software development or IT consulting firms may not be directly comparable due to the unique nature of IPO advisory services and the associated revenue models (cash fees plus warrants/stock options).

Legal Proceedings

• From time to time, the company is involved in various claims and legal actions arising in the ordinary course of business.
• To the knowledge of management, there are no legal proceedings currently pending against the company which are believed to have a material effect on its business, financial position, or results of operations, and no such proceedings are contemplated or threatened.

Related Party Transactions

• Due to related party balances of $460 from Sumitaka Yamamoto (CEO and major shareholder) as of June 30, 2026.
• Accounts payable and accrued expenses to Luvina Software Joint Stock Company (non-controlling shareholder of HeartCore Luvina) were $33,946 as of June 30, 2026.
• Software development services were engaged from Luvina Software Joint Stock Company for $151,143 and $265,678 for the three and six months ended June 30, 2026, respectively.

Stakeholder Impact

• Shareholders may experience further dilution if the company needs to raise additional equity financing.
• The company's ability to continue as a going concern could impact all stakeholders if new funding is not secured.
• The concentration of revenue among fewer customers post-Sigmaways sale increases risk for shareholders.
• Creditors may face increased risk if the company's liquidity situation does not improve.

Next Steps

• Continue to explore strategic alternatives for raising additional funding.
• Restructure operations to grow revenues and decrease expenses.
• Complete the sale of 51% of the outstanding shares of HeartCore Luvina to its non-controlling shareholder.

Key Dates

Recommendation

The company is experiencing significant net losses, a substantial decrease in cash reserves, and a widening gross loss, despite revenue growth in one segment. The ongoing concerns about its ability to continue as a going concern, coupled with increased operational costs and revenue concentration risks post-divestitures, suggest a negative outlook for the stock.

Keywords

Software Development, Consulting Services, Go IPO, Discontinued Operations, Financial Statements, Revenue, Net Loss, Cash Flow